Cravatex FY26 results: ₹167.69cr income, ₹6.8cr profit

Cravatex Ltd has published audited standalone and consolidated financial results for FY2025-26, alongside quarterly disclosures that show a mixed revenue trend but an improvement in profitability. The company’s consolidated total income for the year ended March 2026 stood at ₹167.69 crore, while consolidated net profit for the year rose to ₹6.80 crore.

Market data points in the same information set show multiple price snapshots. One update stated that as of 8 Aug 2026, the Cravatex share price was ₹347.5. Other quotes included ₹375.20 (+0.36%), ₹343.05 (-3.91%), and ₹352.00 (-5.08%), indicating different update times and moves.

FY2025-26 audited results: the headline numbers

Cravatex disclosed that it published its audited standalone and consolidated financial results for FY2025-26 in Business Standard and Sakal on May 16, 2026, citing SEBI Regulations 30 and 47. On a consolidated basis, total income fell compared with the previous year, but profit increased.

Consolidated total income for FY2025-26 was ₹167.69 crore versus ₹183.71 crore in FY2024-25. Consolidated net profit for FY2025-26 came in at ₹6.80 crore, up from ₹4.83 crore in the prior year. Basic EPS for the year was reported at ₹26.30, compared with ₹18.68 in FY2024-25.

Q4 FY2025-26 performance and profit growth

For the quarter ended March 2026 (Q4 FY2025-26), the company reported revenue from operations of ₹39.51 crore, compared with ₹60.52 crore in Q4 FY2024-25. Other income in the quarter was ₹3.30 crore versus ₹2.09 crore a year earlier, taking total income to ₹42.81 crore from ₹62.61 crore.

Despite the lower year-on-year income base, consolidated net profit for Q4 FY2025-26 was ₹1.60 crore compared with ₹1.44 crore in Q4 FY2024-25. Basic EPS for the quarter was ₹6.19 versus ₹5.59.

Result highlights shared for Q4 FY2025-26

The provided highlights also summarised quarter-on-quarter and year-on-year changes. Cravatex reported a 3.6% QoQ increase in consolidated revenues for Q4 FY2025-26, while revenues declined 31.6% YoY. Quarterly expenses were up 2.2% QoQ and down 33.0% YoY.

Net profit was reported as up 18.5% QoQ and up 11.1% YoY. EPS was stated at 6.19 during Q4 FY2025-26. Separately, the net profit line was also described as increasing 11.11% year-on-year to ₹1.60 crore in Q4 FY2025-26 and rising 18.52% on a quarterly basis.

Dividend: ₹13 per share recommendation and key dates

Cravatex’s board recommended a final dividend of ₹13 per share on equity shares of ₹10 each for FY2025-26, subject to shareholder approval. Another disclosure line stated that, in the quarter ending March 2026, the company declared a dividend of ₹13.00 per share on 15 May 2026.

The dataset also lists dividend-related event details: dividend of ₹13 per share, ex-date July 24, 2026, and a quarterly results announcement date of Aug 12, 2026. A dividend yield of 7.39% was cited for the March 2026 quarter in one place, while other snapshots reported dividend yield around 3.46% to 3.51%, reflecting different price references.

Key audited financials (consolidated)

Standalone performance: profit also improved

Alongside consolidated figures, Cravatex disclosed standalone results for FY2025-26. Standalone total income was ₹164.82 crore, up from ₹143.27 crore in the previous year. Standalone net profit stood at ₹5.55 crore versus ₹4.86 crore in FY2024-25.

These standalone numbers indicate that the company reported income growth at the standalone level, while the consolidated total income declined year-on-year. The disclosures do not provide an explanatory note in the supplied text, so the article confines itself to the published figures.

Recent quarterly trend: sales and operating profit swings

Quarterly profit and loss data (in ₹ crore) shows fluctuating sales and operating profit across the last several reported quarters. For example, sales moved from ₹60.52 crore in Mar 2025 to ₹23.13 crore in Jun 2025, and then to ₹39.51 crore in Mar 2026.

Operating profit in this table was negative in several quarters, including -₹0.60 crore in Mar 2026 and -₹6.10 crore in Jun 2025. Total income for Mar 2026 was shown at ₹42.81 crore, including other income of ₹3.30 crore.

Valuation and balance sheet indicators shown in the data

The same information set lists market ratios and operating metrics for the stock, including a P/E ratio of 13.45 and price-to-book of 0.86. Debt to equity was shown at 1.52%, with return on equity at 6.02%.

EBITDA appeared in two snapshots: ₹6.49 crore (64.89M) and ₹10.44 crore (104.39M). Since the source text includes both, they are best read as values captured at different times or from different pages within the data feed.

Stock identity and company profile

Cravatex is described as importing and distributing sports equipment and apparel, providing beauty therapy services, and manufacturing and selling sports and casual wear. The stock is identified as “Cravatex B.O.” in the dataset, and one line states that it is not traded on NSE. The BSE scrip code listed is 509472.

The company address provided is 1st Floor, Godrej Bhavan, 4A Home Street, Charanjit Rai Marg, Fort, Mumbai, Maharashtra 400001, with email investors@cravatex.com and website http://www.cravatex.com.

Why these results matter for investors tracking Cravatex

The audited FY2025-26 numbers show a clear divergence: consolidated total income declined year-on-year, while consolidated net profit improved from ₹4.83 crore to ₹6.80 crore. In Q4, the company reported net profit growth despite a steep drop in revenue from operations year-on-year, supported by other income and lower expenses relative to the prior-year quarter.

The dividend recommendation of ₹13 per share is a concrete shareholder-return signal, with dated milestones such as the May 15, 2026 declaration reference and the July 24, 2026 ex-date listed in the same dataset. Investors typically map these announcements alongside earnings timelines such as the Aug 12, 2026 quarterly results event noted here.

Conclusion

Cravatex’s FY2025-26 disclosures point to improved profitability on both standalone and consolidated bases, even as consolidated income fell from the previous year. The next near-term marker in the provided data is the Aug 12, 2026 quarterly results event, while the ₹13 per share dividend and its July 24, 2026 ex-date are the key corporate action references mentioned.